Bergeron J

No ORCID on file · 1 paper in corpus
article 1988
Fertility and Sterility ·doi:10.1016/s0015-0282(16)59887-2

In order to suppress the pituitary-ovarian axis for treatment of endometriosis, the luteinizing hormone-releasing hormone (LH-RH) agonist buserelin (Hoechst Canada Inc., Montreal, Quebec, Canada) was administered by continuous subcutaneous …